Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension.
Laila WidmannStanislav KeranovLeili JafariChristoph LiebetrauTill KellerChristian TroidlSteffen KriechbaumSandra VossMani ArsalanManuel J RichterKhodr TelloHenning GallHossein A GhofraniStefan GuthWerner SeegerChristian W HammOliver DörrHolger NefPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)
FGF-23 may serve as a biomarker for maladaptive RV remodeling in patients with PH.